Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients

Journal of the International AIDS Society

Volumn 18, Issue 1, 2015, Pages

  Sada Ovalle, Isabel ^a   Ocaña Guzman, Ranferi ^a   Pérez Patrigeón, Santiago ^b   Chávez Galán, Leslie ^a   Sierra Madero, Juan ^b   Torre Bouscoulet, Luis ^a   Addo, Marylyn M ^c,d  

^a Laboratorio de Inmunología Integrativa Instituto   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Research Center Borstel   (Germany)

Author keywords

Galectin 9; HIV; PD 1; Tim 3; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD38 ANTIGEN; ECALECTIN; HLA DR ANTIGEN; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; TIM 3 PROTEIN; UNCLASSIFIED DRUG; HAVCR2 PROTEIN, HUMAN; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; PDCD1 PROTEIN, HUMAN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL GROWTH; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DEATH; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; AIDS RELATED COMPLEX; ANTAGONISTS AND INHIBITORS; COMPLICATION; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HIV INFECTIONS; HUMANS; MACROPHAGES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 84945936582     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.1.20078     Document Type: Article

References (17)

1. WHO (2013). HIV-associated TB facts. http://www.who.int/tb/challenges/hiv/tbhiv-factsheet-2013-web.pdf
2. WHO (2010). The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. Geneva: WHO (WHO/HTM/STB/ 2010.2).
3. Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014;14(7):563-71.
4. Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol. 2011;350:1-15.
5. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated Tcell expression of TIM3 in multiple sclerosis. J Exp Med. 2006; 203(6):1413-8.
6. Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA. 2010;107(33):14733-8.
7. Feuth T, Arends JE, Fransen JH, Nanlohy NM, van Erpecum KJ, Siersema PD, et al. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One. 2013;8(3):59302.
8. Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207(10):2187-94.
9. Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4 + and CD8+ Tcells. J Virol. 2009;83(18):9122-30.
10. Jayaraman P, Sada-Ovalle I, Beladi S, Anderson AC, Dardalhon V, Hotta C, et al. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med. 2010;207(11):2343-54.
11. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog. 2008;4(12):e1000239.
12. Sada-Ovalle I, Chavez-Galan L, Torre-Bouscoulet L, Nava-Gamino L, Barrera L, Jayaraman P, et al. The Tim-3-galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis. J Immunol. 2012;189(12):5896-902.
13. Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med. 2008;205(12): 2763-79.
14. Breton G, Chomont N, Takata H, Fromentin R, Ahlers J, Filali-Mouhim A, et al. Programmed death-1 is a marker for abnormal distribution of naive/ memory T cell subsets in HIV-1 infection. J Immunol. 2013;191(5):2194-204.
15. Rosignoli G, Lim CH, Bower M, Gotch F, Imami N. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals. Clin Exp Immunol. 2009;157(1):90-7.
16. Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, et al. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur J Immunol. 2010;40(9):2493-505.
17. Seung E, Dudek TE, Allen TM, Freeman GJ, Luster AD, Tager AM. PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS One. 2013;8(10):e77780.